Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46720 | 16234011 | Clin Gastroenterol Hepatol | Diagnostic value of quantitative hepatic copper determination in patients with Wilson's Disease. | 2005 | Details |
| A46721 | 16226915 | Hepatol Res | Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. | 2005 | Details |
| A46722 | 16220049 | Curr Opin Gastroenterol | Role of inflammation in nonalcoholic steatohepatitis. | 2005 | Details |
| A46723 | 16186572 | CMAJ | Nonalcoholic fatty liver disease. | 2005 | Details |
| A46724 | 16186570 | CMAJ | Nonalcoholic fatty liver disease. | 2005 | Details |
| A46725 | 16175608 | Hepatology | Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. | 2005 | Details |
| A46726 | 16175602 | Hepatology | Steatohepatitis induced by intragastric overfeeding in mice. | 2005 | Details |
| A46727 | 16175589 | Hepatology | Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2005 | Details |
| A46728 | 16168995 | Atherosclerosis | Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients. | 2005 | Details |
| A46729 | 16161764 | J Nutr Sci Vitaminol (Tokyo) | Influence of royal jelly on mouse hepatic gene expression and safety assessment with a DNA microarray. | 2005 | Details |
| A46730 | 16160540 | Curr Opin Pediatr | Nonalcoholic fatty liver disease in the pediatric population: a review. | 2005 | Details |
| A46731 | 16137470 | Gastroenterol Hepatol | [Nonalcoholic steatohepatitis associated with ovarian stromal hyperplasia]. | 2005 | Details |
| A46732 | 16116643 | Hepatology | The histopathology of pediatric nonalcoholic fatty liver disease. | 2005 | Details |
| A46733 | 16109522 | Hepatobiliary Pancreat Dis Int | Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. | 2005 | Details |
| A46734 | 16098839 | Am J Cardiol | Management of dyslipidemia in patients with complicated metabolic syndrome. | 2005 | Details |
| A46735 | 16085912 | Clin Diagn Lab Immunol | Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. | 2005 | Details |
| A46736 | 16083334 | Expert Opin Emerg Drugs | Nonalcoholic fatty liver disease: a review. | 2005 | Details |
| A46737 | 16053912 | Eur J Med Genet | Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene. | 2005 | Details |
| A46738 | 16011474 | Annu Rev Nutr | Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. | 2005 | Details |
| A46739 | 16004529 | Rev Esp Enferm Dig | [Non-alcoholic fatty liver disease]. | 2005 | Details |
| A46740 | 16000931 | J Clin Gastroenterol | Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. | 2005 | Details |
| A46741 | 15990637 | J Pediatr Gastroenterol Nutr | Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. | 2005 | Details |
| A46742 | 15990591 | Curr Opin Lipidol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2005 | Details |
| A46743 | 15989845 | Med Clin (Barc) | [Medical management of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46744 | 15989823 | Gastroenterol Hepatol | [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver]. | 2005 | Details |
| A46745 | 15980265 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease and atherosclerosis. | 2005 | Details |
| A46746 | 15977205 | Hepatology | Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery. | 2005 | Details |
| A46747 | 15976528 | Alcohol Clin Exp Res | Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression. | 2005 | Details |
| A46748 | 15974230 | Trop Gastroenterol | Nonalcoholic fatty liver disease in India--how much? How soon? | 2005 | Details |
| A46749 | 15968747 | World J Gastroenterol | Nonalcoholic fatty liver disease in developing countries. | 2005 | Details |
| A46750 | 15926473 | Nihon Naika Gakkai Zasshi | [From fatty liver to liver cancer--new development in non-alcoholic steatohepatitis (NASH) using animal models]. | 2005 | Details |
| A46751 | 15920084 | Diabetes Care | Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease. | 2005 | Details |
| A46752 | 15913829 | J Hepatol | Signalling links in the liver: knitting SOCS with fat and inflammation. | 2005 | Details |
| A46753 | 15908310 | Hepatobiliary Pancreat Dis Int | Obesity, fatty liver and liver cancer. | 2005 | Details |
| A46754 | 15883252 | Arch Intern Med | Serum ferritin levels in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A46755 | 15882516 | Med Clin (Barc) | [Pathogenesis of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46756 | 15855597 | Diabetes Care | Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. | 2005 | Details |
| A46757 | 15842599 | Am J Gastroenterol | The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A46758 | 15818156 | Curr Opin Gastroenterol | Pediatric hepatobiliary disease. | 2005 | Details |
| A46759 | 15810122 | Gastroenterology | Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. | 2005 | Details |
| A46760 | 15795412 | CMAJ | Nonalcoholic fatty liver disease. | 2005 | Details |
| A46761 | 15793879 | World J Gastroenterol | Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. | 2005 | Details |
| A46762 | 15779390 | Nihon Rinsho | [Impaired glucose tolerance in nonalcoholic fatty liver disease]. | 2005 | Details |
| A46763 | 15763233 | Clin Liver Dis | Long-term management of alcoholic liver disease. | 2005 | Details |
| A46764 | 15753852 | Transplantation | Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. | 2005 | Details |
| A46765 | 15730035 | Ned Tijdschr Geneeskd | [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis]. | 2005 | Details |
| A46766 | 15728360 | Proc Natl Acad Sci U S A | Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. | 2005 | Details |
| A46767 | 15727708 | Zhonghua Gan Zang Bing Za Zhi | [Evaluation of treatments for nonalcoholic fatty liver disease]. | 2005 | Details |
| A46768 | 15727706 | Zhonghua Gan Zang Bing Za Zhi | [Drug therapy for nonalcoholic fatty liver disease]. | 2005 | Details |
| A46769 | 15727705 | Zhonghua Gan Zang Bing Za Zhi | [Treatment of nonalcoholic fatty liver disease: behavior modification, diet therapy and exercise programs]. | 2005 | Details |
| A46770 | 15727688 | Zhonghua Gan Zang Bing Za Zhi | [Glucotoxicity, lipotoxicity and the nonalcoholic fatty liver disease]. | 2005 | Details |
| A46771 | 15705403 | Fertil Steril | Abnormal aminotransferase activity in women with polycystic ovary syndrome. | 2005 | Details |
| A46772 | 15703643 | Curr Opin Gastroenterol | Hepatobiliary pathology. | 2004 | Details |
| A46773 | 15703606 | Curr Opin Gastroenterol | Innate immunity in the liver. | 2003 | Details |
| A46774 | 15703564 | Curr Opin Gastroenterol | Hepatocellular carcinoma. | 2003 | Details |
| A46775 | 15682682 | J Investig Med | Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. | 2004 | Details |
| A46776 | 15670659 | Alcohol | Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium. | 2004 | Details |
| A46777 | 15659701 | Pediatr Res | Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. | 2005 | Details |
| A46778 | 15650132 | Am J Physiol Gastrointest Liver Physiol | Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet. | 2005 | Details |
| A46779 | 15632182 | J Biol Chem | Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. | 2005 | Details |
| A46780 | 15619243 | Hepatology | Progress in understanding the pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A46781 | 15611492 | Ann Intern Med | Narrative review: hepatobiliary disease in type 2 diabetes mellitus. | 2004 | Details |
| A46782 | 15610470 | J Gastroenterol Hepatol | What is the best indicator for evaluating treatment response in nonalcoholic fatty liver disease: histology or aminotransferase levels? | 2005 | Details |
| A46783 | 15610304 | J Gastroenterol Hepatol | Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease. | 2004 | Details |
| A46784 | 15605304 | Semin Liver Dis | Liver pathology in obesity. | 2004 | Details |
| A46785 | 15598693 | J Clin Endocrinol Metab | Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. | 2004 | Details |
| A46786 | 15578508 | Gastroenterology | Serum markers detect the presence of liver fibrosis: a cohort study. | 2004 | Details |
| A46787 | 15571010 | Dig Liver Dis | Coeliac disease and non-alcoholic fatty liver disease. | 2004 | Details |
| A46788 | 15547646 | Angiology | Prevention and treatment of the metabolic syndrome. | 2005 | Details |
| A46789 | 15531238 | J Gastrointest Surg | Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. | 2004 | Details |
| A46790 | 15519275 | Hepatol Res | Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis. | 2004 | Details |
| A46791 | 15508909 | Nutr Rev | Central obesity and elevated liver enzymes. | 2004 | Details |
| A46792 | 15508109 | Gastroenterology | Obesity and hepatocellular carcinoma. | 2004 | Details |
| A46793 | 15505596 | Ann Hepatol | Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial. | 2005 | Details |
| A46794 | 15492608 | J Clin Gastroenterol | Relationship between unexplained elevations in alanine aminotransferase and serum leptin in U.S. adults: results from the Third National Health and Nutrition Examination Survey (NHANES III). | 2005 | Details |
| A46795 | 15382171 | Hepatology | Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. | 2004 | Details |
| A46796 | 15349802 | Semin Liver Dis | Diagnosis and therapy of alcoholic liver disease. | 2004 | Details |
| A46797 | 15345470 | Am J Physiol Gastrointest Liver Physiol | Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. | 2004 | Details |
| A46798 | 15338491 | J Rheumatol | Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. | 2004 | Details |
| A46799 | 15333965 | Indian J Gastroenterol | Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought. | 2004 | Details |
| A46800 | 15331070 | Clin Liver Dis | Management of nonalcoholic fatty liver disease: weight control. | 2004 | Details |
| A46801 | 15331066 | Clin Liver Dis | Mitochondria in nonalcoholic fatty liver disease. | 2004 | Details |
| A46802 | 15262299 | Endocrinol Metab Clin North Am | Glitazones and the management of insulin resistance: what they do and how might they be used. | 2004 | Details |
| A46803 | 15254578 | J Clin Invest | Molecular mediators of hepatic steatosis and liver injury. | 2004 | Details |
| A46804 | 15240880 | Proc Natl Acad Sci U S A | Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. | 2004 | Details |
| A46805 | 15208756 | Clin Pediatr (Phila) | Non-alcoholic fatty liver disease in a toddler. | 2004 | Details |
| A46806 | 15195530 | Gastroenterol Hepatol | [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets]. | 2004 | Details |
| A46807 | 15178501 | Am J Med | Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia. | 2004 | Details |
| A46808 | 15151470 | Expert Rev Cardiovasc Ther | Treatment of metabolic syndrome. | 2004 | Details |
| A46809 | 15122714 | Ann Neurol | Valproate therapy and nonalcoholic fatty liver disease. | 2004 | Details |
| A46810 | 15086699 | Intern Med J | Nonalcoholic fatty liver disease: is all the fat bad? | 2004 | Details |
| A46811 | 15051828 | J Nutr | Mice heterozygous for Atp10c, a putative amphipath, represent a novel model of obesity and type 2 diabetes. | 2004 | Details |
| A46812 | 15030972 | J Hepatol | The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. | 2004 | Details |
| A46813 | 15017614 | Clin Gastroenterol Hepatol | Liver abnormalities in celiac disease. | 2004 | Details |
| A46814 | 14985206 | Am J Clin Nutr | Another animal model for nonalcoholic steatohepatitis: how close to the human condition? | 2004 | Details |
| A46815 | 14976879 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [About non-alcoholic lipoidal liver disease]. | 2004 | Details |
| A46816 | 14752843 | Hepatology | Vascular involvement of the liver in Turner's syndrome. | 2004 | Details |
| A46817 | 14749503 | Recent Prog Horm Res | Obesity, insulin resistance, and cardiovascular disease. | 2004 | Details |
| A46818 | 14720455 | Curr Gastroenterol Rep | New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments. | 2004 | Details |
| A46819 | 14720451 | Curr Gastroenterol Rep | Controversies in liver biopsy: who, where, when, how, why? | 2004 | Details |